from Reuters: Health News https://ift.tt/2LVRuSx
Friday, August 3, 2018
Friday, August 03, 2018
MZ Digital Marketing Agency
HEALTH NEWS
No comments
Privately held Celtaxsys Inc said on Thursday a mid-stage trial testing its experimental cystic fibrosis treatment was successful in reducing a key symptom of the genetic lung disease, but did not improve lung function.

from Reuters: Health News https://ift.tt/2LVRuSx
from Reuters: Health News https://ift.tt/2LVRuSx
Related Posts:
LATEST HEALTH NEWSAn advisory panel to the U.S. Food and Drug Administration on Friday recommended Sage Therapeutics Inc's experimental treatment for postpartum depression, saying the benefits of the drug outweighed risks. from Reuters: H… Read More
LATEST HEALTH NEWS(Reuters Health) - Standing above the crowd puts people at greater risk of developing varicose veins, a large genetic study suggests. from Reuters: Health News https://ift.tt/2RyaN3K … Read More
LATEST HEALTH NEWS(Reuters Health) - Teens seeking to buy emergency contraception at pharmacies continue to face significant roadblocks, a new U.S. study suggests. from Reuters: Health News https://ift.tt/2PEljsK … Read More
LATEST HEALTH NEWSThe U.S. Food and Drug Administration on Friday approved AcelRx Pharmaceuticals Inc's opioid-based treatment for pain to be used under strict medical supervision, with the agency's chief highlighting reasons for the approval … Read More
LATEST HEALTH NEWSTrevena Inc shares plunged 45 percent on Friday after the U.S. Food and Drug Administration declined to approve its opioid injection for managing acute pain, citing inadequate safety data. from Reuters: Health News https… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment